Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Inivata Launches Major US Study To Back Liquid Biopsy Tech In Lung Cancer

Executive Summary

Cambridge University spin-out Inivata has launched a major US clinical validation study to evaluate its liquid biopsy approach against tissue-based diagnostic methods in non-small cell lung cancer patients.

Advertisement

Related Content

Liquid Biopsy In Oncology: An Increasingly Crowded Landscape

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register